CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.
Capital Com Australia Pty Ltd Australia (Regulated by ASIC) Capital Com UK Limited Authorised and regulated by the Financial Conduct Authority (FCA) Capital Com SV Investments Limited Cyprus / EU (Regulated by CYSEC) Сlosed Joint Stock Company «FinTech Solutions» (Regulated by NBRB) Smart Forex Broker LLC Capital Com Stock and CFD Investing Ltd Seychelles (Regulated by FSA) Capital Com Online Investments Ltd (Regulated by SCB) Our Global Offices

Scan to Download iOS&Android APP

English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文
Anda juga dapat menghubungi kami: hubungi +44 2030978888 support@capital.com

Perdagangan Bolt Biotherapeutics, Inc. - BOLT CFD

1.4076
2.76%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.0148
Biaya inap posisi Long

Long position overnight fee

Margin. Your investment $1,000.00
Biaya Overnight -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Kunjungi platform
-0.024068%
Biaya inap posisi short

Short position overnight fee

Margin. Your investment $1,000.00
Biaya Overnight 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Kunjungi platform
0.001846%
Waktu biaya inap 21:00 (UTC)
Kuantitas min. yang diperdagangkan 1
Mata uang USD
Margin 20%
Bursa efek United States of America
Komisi perdagangan 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 1.4475
Open* 1.3976
1-Year Change* -51.97%
Day's Range* 1.3876 - 1.4276
52 wk Range 1.18-3.24
Average Volume (10 days) 200.73K
Average Volume (3 months) 5.96M
Market Cap 53.86M
P/E Ratio -100.00K
Shares Outstanding 37.66M
Revenue 4.83M
EPS -2.55
Dividend (Yield %) N/A
Beta -100.00K
Next Earnings Date N/A

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 22, 2023 1.4076 -0.0599 -4.08% 1.4675 1.4675 1.3776
Mar 21, 2023 1.4475 0.0499 3.57% 1.3976 1.4975 1.3776
Mar 20, 2023 1.4176 0.0200 1.43% 1.3976 1.4376 1.3676
Mar 17, 2023 1.4176 -0.0499 -3.40% 1.4675 1.4875 1.3976
Mar 16, 2023 1.4975 0.0699 4.90% 1.4276 1.5174 1.4176
Mar 15, 2023 1.4675 0.0699 5.00% 1.3976 1.4975 1.3976
Mar 14, 2023 1.5075 0.1099 7.86% 1.3976 1.5075 1.3976
Mar 13, 2023 1.3976 0.1098 8.53% 1.2878 1.4076 1.2678
Mar 10, 2023 1.2678 -0.1198 -8.63% 1.3876 1.3877 1.2678
Mar 9, 2023 1.3876 -0.1298 -8.55% 1.5174 1.5674 1.3677
Mar 8, 2023 1.5773 -0.0200 -1.25% 1.5973 1.5973 1.5274
Mar 7, 2023 1.6073 0.0599 3.87% 1.5474 1.6273 1.5474
Mar 6, 2023 1.5674 -0.0898 -5.42% 1.6572 1.6672 1.5174
Mar 3, 2023 1.6373 0.0200 1.24% 1.6173 1.7071 1.6173
Mar 2, 2023 1.6173 0.0400 2.54% 1.5773 1.6672 1.5773
Mar 1, 2023 1.6472 0.1298 8.55% 1.5174 1.6772 1.5174
Feb 28, 2023 1.5973 0.0799 5.27% 1.5174 1.6173 1.5174
Feb 27, 2023 1.5873 0.0499 3.25% 1.5374 1.6173 1.4874
Feb 24, 2023 1.5374 0.0100 0.65% 1.5274 1.5574 1.5074
Feb 23, 2023 1.5574 0.1099 7.59% 1.4475 1.5674 1.4276

Bolt Biotherapeutics, Inc. Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2021 2020 2019 2018
Total revenue 1.26 0.231 0.215 0
Revenue 1.26 0.231 0.215 0
Total Operating Expense 94.048 49.413 31.184 11.629
Selling/General/Admin. Expenses, Total 18.393 9.056 5.182 2.209
Research & Development 75.655 40.357 26.002 9.42
Operating Income -92.788 -49.182 -30.969 -11.629
Interest Income (Expense), Net Non-Operating 0.281 0.199 0.524 0.193
Other, Net -6.084 -11.745 -0.042 -0.153
Net Income Before Taxes -98.591 -60.728 -30.487 -11.589
Net Income After Taxes -98.591 -60.728 -30.487 -11.589
Net Income Before Extra. Items -98.591 -60.728 -30.487 -11.589
Net Income -98.591 -60.728 -30.487 -11.589
Income Available to Common Excl. Extra. Items -98.591 -60.728 -30.487 -11.589
Income Available to Common Incl. Extra. Items -98.591 -60.728 -30.487 -11.589
Diluted Net Income -98.591 -60.728 -30.487 -11.589
Diluted Weighted Average Shares 33.1967 36.3279 34.5218 34.5218
Diluted EPS Excluding Extraordinary Items -2.9699 -1.67166 -0.88312 -0.3357
Dividends per Share - Common Stock Primary Issue 0 0
Diluted Normalized EPS -2.9699 -1.67166 -0.88312 -0.3357
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Total revenue 0.813 0.508 0.752 0 0
Revenue 0.813 0.508 0.752 0 0
Total Operating Expense 24.689 27.583 24.278 23.761 18.426
Selling/General/Admin. Expenses, Total 6.304 5.099 4.941 4.054 4.299
Research & Development 18.385 22.484 19.337 19.707 14.127
Operating Income -23.876 -27.075 -23.526 -23.761 -18.426
Interest Income (Expense), Net Non-Operating 0.198 -0.082 0.131 0.176 0.056
Other, Net 0 0 0 0 -6.084
Net Income Before Taxes -23.678 -27.157 -23.395 -23.585 -24.454
Net Income After Taxes -23.678 -27.157 -23.395 -23.585 -24.454
Net Income Before Extra. Items -23.678 -27.157 -23.395 -23.585 -24.454
Net Income -23.678 -27.157 -23.395 -23.585 -24.454
Income Available to Common Excl. Extra. Items -23.678 -27.157 -23.395 -23.585 -24.454
Income Available to Common Incl. Extra. Items -23.678 -27.157 -23.395 -23.585 -24.454
Diluted Net Income -23.678 -27.157 -23.395 -23.585 -24.454
Diluted Weighted Average Shares 37.1279 37.3143 37.2068 36.5951 21.4983
Diluted EPS Excluding Extraordinary Items -0.63774 -0.72779 -0.62878 -0.64448 -1.13748
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.63774 -0.72779 -0.62878 -0.64448 -1.13748
  • Annual
  • Quarterly
2021 2020 2019 2018
Total Current Assets 189.16 25.361 35.9 14.1
Cash and Short Term Investments 186.219 22.838 34.826 13.634
Cash & Equivalents 27.383 5.542 34.826 13.634
Short Term Investments 158.836 17.296 0 0
Prepaid Expenses 2.941 2.523 1.074 0.466
Total Assets 307.718 46.542 48.447 15.975
Property/Plant/Equipment, Total - Net 30.603 16.384 11.517 1.442
Property/Plant/Equipment, Total - Gross 32.848 17.623 12.162 1.856
Accumulated Depreciation, Total -2.245 -1.239 -0.645 -0.414
Other Long Term Assets, Total 2.607 4.797 1.03 0.433
Total Current Liabilities 21.328 11.264 8.656 2.755
Accounts Payable 3.574 1.598 2.095 0.892
Accrued Expenses 14.885 8.164 5.962 1.823
Notes Payable/Short Term Debt 0 0 0 0
Current Port. of LT Debt/Capital Leases 0 0.04
Other Current Liabilities, Total 2.869 1.502 0.599 0
Total Liabilities 57.599 46.193 16.788 3.551
Total Long Term Debt 0 0 0 0
Other Liabilities, Total 36.271 34.929 8.132 0.796
Total Equity 250.119 0.349 31.659 12.424
Preferred Stock - Non Redeemable, Net 105.296 77.505 28.367
Common Stock 0.00037 0.00036 0 0
Additional Paid-In Capital 457.43 3.452 1.825 1.241
Retained Earnings (Accumulated Deficit) -206.99 -108.399 -47.671 -17.184
Other Equity, Total -0.32137 -0.00036 0 0
Total Liabilities & Shareholders’ Equity 307.718 46.542 48.447 15.975
Total Common Shares Outstanding 37.3997 36.3279 34.5218 34.5218
Long Term Investments 85.348
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Total Current Assets 196.088 189.16 222.488 248.151 271.21
Cash and Short Term Investments 190.901 186.219 212.893 244.988 266.669
Cash & Equivalents 44.021 27.383 23.649 58.302 95.481
Short Term Investments 146.88 158.836 189.244 186.686 171.188
Prepaid Expenses 5.187 2.941 9.595 3.163 4.541
Total Assets 282.793 307.718 333.55 347.074 324.637
Property/Plant/Equipment, Total - Net 29.911 30.603 30.868 30.553 15.418
Property/Plant/Equipment, Total - Gross 32.518 32.848 32.926 32.311 16.925
Accumulated Depreciation, Total -2.607 -2.245 -2.058 -1.758 -1.507
Long Term Investments 54.313 85.348 77.639 65.938 36.236
Other Long Term Assets, Total 2.481 2.607 2.555 2.432 1.773
Total Current Liabilities 19.306 21.328 23.695 19.25 12.012
Accounts Payable 4.446 3.574 5.155 1.614 2.888
Accrued Expenses 11.412 14.885 13.333 13.306 7.622
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 3.448 2.869 5.207 4.33 1.502
Total Liabilities 54.399 57.599 58.637 51.178 21.389
Total Long Term Debt 0 0 0 0 0
Other Liabilities, Total 35.093 36.271 34.942 31.928 9.377
Total Equity 228.394 250.119 274.913 295.896 303.248
Preferred Stock - Non Redeemable, Net 0 0 0
Common Stock 0.00037 0.00037 0.00037 0.00037 0.00036
Additional Paid-In Capital 460.458 457.43 454.784 452.357 436.165
Retained Earnings (Accumulated Deficit) -230.668 -206.99 -179.833 -156.438 -132.853
Other Equity, Total -1.39637 -0.32137 -0.03837 -0.02337 -0.06436
Total Liabilities & Shareholders’ Equity 282.793 307.718 333.55 347.074 324.637
Total Common Shares Outstanding 37.4713 37.3997 37.2481 37.191 36.3318
  • Annual
  • Quarterly
2021 2020 2019 2018
Net income/Starting Line -98.591 -60.728 -30.487 -11.589
Cash From Operating Activities -57.066 -47.308 -26.343 -9.872
Cash From Operating Activities 1.193 0.611 0.335 0.302
Non-Cash Items 19.825 15.092 1.544 0.276
Cash Interest Paid 0 0.004
Changes in Working Capital 20.507 -2.283 2.265 1.139
Cash From Investing Activities -232.201 -20.592 -0.508 -0.29
Capital Expenditures -2.338 -3.262 -0.508 -0.29
Other Investing Cash Flow Items, Total -229.863 -17.33 0 0
Cash From Financing Activities 311.108 39.597 48.627 19.094
Financing Cash Flow Items 0 39.303 48.595 19.113
Issuance (Retirement) of Stock, Net 311.108 0.294 0.072 0.02
Issuance (Retirement) of Debt, Net 0 -0.04 -0.039
Net Change in Cash 21.841 -28.303 21.776 8.932
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -23.678 -98.591 -71.434 -48.039 -24.454
Cash From Operating Activities -24.314 -57.066 -39.272 -20.545 -16.559
Cash From Operating Activities 0.357 1.193 0.832 0.528 0.272
Non-Cash Items 4.556 19.825 16.21 12.401 8.994
Changes in Working Capital -5.549 20.507 15.12 14.565 -1.371
Cash From Investing Activities 40.845 -232.201 -253.234 -237.123 -190.521
Capital Expenditures -0.605 -2.338 -1.776 -0.761 -0.058
Other Investing Cash Flow Items, Total 41.45 -229.863 -251.458 -236.362 -190.463
Cash From Financing Activities 0.107 311.108 310.613 310.428 297.019
Issuance (Retirement) of Stock, Net 0.107 311.108 310.613 310.428 297.019
Net Change in Cash 16.638 21.841 18.107 52.76 89.939
Financing Cash Flow Items 0
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Vivo Capital, LLC Venture Capital 10.2793 3871291 0 2022-12-31 MED
Sofinnova Investments, Inc Venture Capital 7.3138 2754437 0 2022-12-31 MED
Citadel Advisors LLC Hedge Fund 7.3077 2752162 114 2022-12-31 HIGH
Pivotal Bioventure Partners Investment Advisor LLC Investment Advisor 5.0224 1891467 0 2022-12-31 LOW
Engleman Edgar G Individual Investor 3.2402 1220280 -57947 2022-03-01
Nan Fung Group Holdings Ltd Corporation 3.0986 1166952 0 2022-12-31 LOW
Newtyn Management, LLC Hedge Fund 3.0536 1150000 550000 2022-12-31 MED
Samsara BioCapital, LLC Venture Capital 2.7858 1049153 0 2022-12-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.4648 928276 -11993 2022-12-31 LOW
OrbiMed Advisors, LLC Investment Advisor/Hedge Fund 2.0474 771059 0 2022-12-31 LOW
Stanford Management Company Endowment Fund 1.9106 719546 0 2022-12-31 MED
Renaissance Technologies LLC Hedge Fund 1.1724 441539 47681 2022-12-31 HIGH
Hawkeye Capital Management, LLC Hedge Fund 1.102 415039 0 2022-12-31 MED
Tang Capital Management, LLC Hedge Fund 1.0621 400000 200000 2022-12-31 MED
Goldman Sachs & Company, Inc. Research Firm 0.7515 283028 270883 2022-12-31 MED
Oasis Management Company Ltd. Investment Advisor/Hedge Fund 0.7435 280000 0 2022-12-31 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 0.7131 268547 -153412 2022-12-31 LOW
Millennium Management LLC Hedge Fund 0.6463 243401 125022 2022-12-31 HIGH
Assenagon Asset Management S.A. Investment Advisor 0.5996 225816 -54165 2022-12-31 HIGH
Bridgeway Capital Management, LLC Investment Advisor 0.4981 187600 74400 2022-12-31 LOW

Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

Capital.com Group

500K+

Trader

92K+

Klien aktif per bulan

$53M+

Volume investasi per bulan

$30M+

Penarikan tiap bulan

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long
Past performance is not a reliable indicator of future results
Laba/Loss
Industry: Bio Therapeutic Drugs

900 Chesapeake Drive
REDWOOD CITY
CALIFORNIA 94063
US

Income Statement

  • Annual
  • Quarterly

People also watch

XRP/USD

0.42 Price
-14.270% 1D Chg, %
Biaya inap posisi Long -0.0753%
Biaya inap posisi short 0.0069%
Waktu biaya inap 21:00 (UTC)
Spread 0.00339

BTC/USD

27,458.55 Price
-2.380% 1D Chg, %
Biaya inap posisi Long -0.0616%
Biaya inap posisi short 0.0137%
Waktu biaya inap 21:00 (UTC)
Spread 60.00

US100

12,637.10 Price
-0.850% 1D Chg, %
Biaya inap posisi Long -0.0241%
Biaya inap posisi short 0.0018%
Waktu biaya inap 21:00 (UTC)
Spread 1.8

Oil - Crude

70.13 Price
+0.880% 1D Chg, %
Biaya inap posisi Long -0.0170%
Biaya inap posisi short -0.0050%
Waktu biaya inap 21:00 (UTC)
Spread 0.03

Masih mencari broker yang bisa Anda percayai?

Bergabung dengan 500.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda